Aarey Drugs & Pharmaceuticals Shows Resilience Amid Declining Investor Participation
Aarey Drugs & Pharmaceuticals Ltd has gained attention by reaching its upper circuit limit, with an intraday high of Rs 55.35. The stock has shown resilience, outperforming its sector and achieving a cumulative return over the past two days. However, investor participation has declined significantly.
Aarey Drugs & Pharmaceuticals Ltd, a microcap player in the trading industry, has captured attention today by hitting its upper circuit limit. The stock reached an intraday high of Rs 55.35, reflecting a notable increase of 4.11% from its previous trading session. Despite a slight decline in the last traded price to Rs 52.62, the stock has shown resilience, outperforming its sector by 0.46% and achieving a 1D return of 1.68%.The trading volume today was approximately 0.32337 lakh shares, with a turnover of Rs 0.1747 crore. The stock has been on a positive trajectory, gaining for the last two days with a cumulative return of 0.87% during this period. Notably, Aarey Drugs & Pharmaceuticals is currently trading above its 20-day, 50-day, and 100-day moving averages, indicating a favorable short-term trend.
However, it is worth mentioning that investor participation has seen a decline, with delivery volume dropping by 60.35% compared to the five-day average. Overall, Aarey Drugs & Pharmaceuticals Ltd's performance today highlights its strong market position within the trading sector, despite fluctuations in investor activity.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
